Label-free quantitative proteomic analysis reveals potential biomarkers for early healing in cutaneous leishmaniasis
Background Leishmaniasis is a parasitic disease caused by more than 20 species of the Leishmania genus. The disease is globally distributed and is endemic in 97 countries and three territories in the tropical and subtropical regions. The efficacy of the current treatments is becoming increasingly lo...
Main Authors: | Andrés Montoya, Manuel Carlos López, Ivan D. Vélez, Sara M. Robledo |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/6228.pdf |
Similar Items
-
Biomarkers of Cutaneous Leishmaniasis
by: Fariborz Bahrami, et al.
Published: (2018-06-01) -
Disseminated Cutaneous Leishmaniasis in Colombia: Report of 27 Cases
by: Iván D. Vélez, et al.
Published: (2015-10-01) -
Urban Cutaneous Leishmaniasis in North of Tehran
by: Aref Saleh Zadeh, et al.
Published: (1997-03-01) -
Comparison of Th1 and Th2 Responses in Non-Healing and Healing Patients with Cutaneous Leishmaniasis
by: Maryam Shahi, et al.
Published: (2013-05-01) -
Study of therapeutic effect of different concentrations of imatinib on Balb/c model of cutaneous leishmaniasis
by: Mohsen Moslehi, et al.
Published: (2020-07-01)